A Phase 1 Open-label, Three Arm Study in Healthy Adult Volunteers to Assess Vadadustat as a Perpetrator in Drug-Drug-Interactions With Digoxin, Adefovir and Furosemide
Latest Information Update: 08 May 2021
At a glance
- Drugs Adefovir (Primary) ; Digoxin (Primary) ; Furosemide (Primary) ; Vadadustat (Primary)
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Akebia Therapeutics
Most Recent Events
- 25 Mar 2021 According to an Akebia Therapeutics media release, data from this trial will be presented at the National Kidney Foundation 2021 Spring Clinical Meetings (NKF SCM21)
- 20 Mar 2019 Status changed from active, no longer recruiting to completed.
- 17 Jan 2019 New trial record